Ovation Science Inc. Announces Investor Consultant

Ovation Science (CSE OVAT)
Published on: June 1, 2020

Vancouver, BC – June 1, 2020 (CSE: OVAT) – Ovation Science Inc. (“Ovation” or the “Company”) is pleased to announce that it has entered into an Investor Relations Agreement with Kin Communications Inc. (the “Consultant”) to provide investor relations services to the Company. The agreement with the Consultant is effective June 1, 2020.

In consideration for the services, the Company will pay the Consultant $7,500, plus G.S.T. on a monthly basis increasing after the third month to $10,000 per month plus GST. The agreement may be terminated by the Company on 30 days notice. The Company has, subject to regulatory approval, granted the Consultant stock options entitling the Consultant to purchase 200,000 common shares of the Company at a price of $0.50 per share for a term of one year.

About Ovation Science Inc.

Ovation Science Inc. is a company that licenses its proprietary topical and transdermal product formulations made with its patented Invisicare® skin delivery technology. Invisicare, used in Ovation’s topical and transdermal products, enhances the delivery of active ingredients to and through the skin. The Company has developed a line of cannabis (CBD) products plus it has a unique hand sanitizer without alcohol, DermSafe.

www.ovationscience.com

Neither Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Contact:

FOR INVESTOR RELATIONS:

Dave Ryan [email protected]

Phone 604.283.0903 ext. 2

FOR BUSINESS DEVELOPMENT & CORPORATE INQUIRIES:

Doreen McMorran

[email protected]

Phone: 604.283.0903 ext. 4

Cannabis Life Science